https://www.marketscreener.com/news/latest/EpimAb-Biotherapeutics-Raises-120M-in-Series-C-Financing-to-Advance-Bispecific-Programs-and-Broad-32758599/?utm_source=telegram&utm_medium=social&utm_campaign=share